Corteva, Inc., through its Corteva Catalyst platform, has provided supplemental funding to Micropep Technologies, contributing to the successful close of its Series B funding round. This investment brings Micropep's total Series B round to $40 million and elevates the company's total funding to over $60 million. The capital infusion is designated to propel ongoing support for Micropep’s pipeline of sustainable micropeptide solutions.
Micropep's proprietary Krisalix™ discovery platform is central to its operations, enabling the rapid discovery of new micropeptide molecules. These micropeptides offer efficient and environmentally friendly crop protection, combining new modes of action with strong efficacy and a favorable safety profile. This technology provides a solution to increasing resistance to traditional chemical alternatives.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.